End-of-day quote
New Zealand S.E.
03:30:00 07/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.001
NZD
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: March |
2018
|
2019
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5.01
|
3.804
|
35.98
|
42.57
|
21.28
|
Enterprise Value (EV)
1 |
5.282
|
4.638
|
63.63
|
57.31
|
50.1
|
P/E ratio
|
-2.25
x
|
-1.79
x
|
333
x
|
21.1
x
|
31.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.89
x
|
20
x
|
7.42
x
|
2.24
x
|
0.91
x
|
EV / Revenue
|
7.27
x
|
24.4
x
|
13.1
x
|
3.02
x
|
2.14
x
|
EV / EBITDA
|
-2.34
x
|
-1.99
x
|
225
x
|
20
x
|
15.8
x
|
EV / FCF
|
-5.36
x
|
417
x
|
-
|
22.3
x
|
-4.47
x
|
FCF Yield
|
-18.7%
|
0.24%
|
-
|
4.49%
|
-22.4%
|
Price to Book
|
21.5
x
|
-3.18
x
|
2.55
x
|
2.29
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
5,56,709
|
19,01,797
|
1,79,89,481
|
2,12,84,975
|
2,12,84,975
|
Reference price
2 |
0.009000
|
0.002000
|
0.002000
|
0.002000
|
0.001000
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/06/21
|
30/06/22
|
30/06/23
|
Fiscal Period: March |
2018
|
2019
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.727
|
0.19
|
4.848
|
19
|
23.46
|
EBITDA
1 |
-2.255
|
-2.327
|
0.2824
|
2.862
|
3.166
|
EBIT
1 |
-2.266
|
-2.336
|
0.2032
|
2.721
|
2.328
|
Operating Margin
|
-311.69%
|
-1,229.47%
|
4.19%
|
14.32%
|
9.92%
|
Earnings before Tax (EBT)
1 |
-2.412
|
-2.401
|
-0.204
|
1.944
|
0.463
|
Net income
1 |
-2.412
|
-2.401
|
0.0448
|
2.027
|
0.692
|
Net margin
|
-331.77%
|
-1,263.68%
|
0.92%
|
10.67%
|
2.95%
|
EPS
2 |
-0.004000
|
-0.001115
|
0.000006
|
0.000095
|
0.000032
|
Free Cash Flow
1 |
-0.9861
|
0.0111
|
-
|
2.573
|
-11.22
|
FCF margin
|
-135.63%
|
5.86%
|
-
|
13.55%
|
-47.81%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
89.92%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
126.95%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/06/21
|
30/06/22
|
30/06/23
|
Fiscal Period: March |
2018
|
2019
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.27
|
0.83
|
27.7
|
14.7
|
28.8
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.1206
x
|
-0.3584
x
|
97.92
x
|
5.151
x
|
9.101
x
|
Free Cash Flow
1 |
-0.99
|
0.01
|
-
|
2.57
|
-11.2
|
ROE (net income / shareholders' equity)
|
-265%
|
864%
|
-
|
11.4%
|
3.58%
|
ROA (Net income/ Total Assets)
|
-68.3%
|
-151%
|
-
|
3.1%
|
2.36%
|
Assets
1 |
3.531
|
1.592
|
-
|
65.41
|
29.32
|
Book Value Per Share
2 |
0
|
-0
|
0
|
0
|
0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
Capex
1 |
0.04
|
-
|
3.88
|
0.49
|
13.9
|
Capex / Sales
|
5.36%
|
-
|
80.07%
|
2.55%
|
59.18%
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/06/21
|
30/06/22
|
30/06/23
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 12.94M | | +20.68% | 85.55B | | -29.31% | 70.07B | | +7.04% | 28.95B | | -8.63% | 17.51B | | +1.82% | 17.39B | | +0.39% | 15.38B | | +6.47% | 13.4B | | +68.09% | 12.93B | | +5.24% | 12.77B |
Other Healthcare Facilities & Services
|